Last reviewed · How we verify
NCT05763459
A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects
Phase 1 trial testing ABBV-CLS-7262 in Healthy in 12 participants. Completed in 2 June 2023.
8 May 2023
Quick facts
| Lead sponsor | Calico Life Sciences LLC |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 24 March 2023 |
| Primary completion | 8 May 2023 |
| Estimated completion | 2 June 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- ABBV-CLS-7262 — full drug profile →
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Calico Life Sciences LLC — full company profile →
Who can join
Adults 18 to 65, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study follows an open-label, single arm design with two periods with rosuvastatin, digoxin and ABBV-CLS-7262
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05763459
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ABBV-CLS-7262
Trials testing the same drug.
- NCT06310876 — A Thorough QT Study of ABBV-CLS-7262 in Healthy Subjects · Phase 1 · completed
- NCT06145607 — A Phase 1 Study Assessing the Effect of Food on the Pharmacokinetics of ABBV- CLS-7262 · Phase 1 · completed
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Calico Life Sciences LLC trials
Trials by the same sponsor.
- NCT06425003 — Study of [14C] ABBV-CLS-7262 in Healthy Male Volunteers Following Single Oral Dose Administration · Phase 1 · completed
- NCT06310876 — A Thorough QT Study of ABBV-CLS-7262 in Healthy Subjects · Phase 1 · completed
- NCT06145607 — A Phase 1 Study Assessing the Effect of Food on the Pharmacokinetics of ABBV- CLS-7262 · Phase 1 · completed
- NCT06188975 — Expanded Access to ABBV-CLS-484 · available
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05763459 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Calico Life Sciences LLC
- Last refreshed: 26 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05763459.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing